APA

Revesz L., Schlapbach A., Aichholz R., Feifel R., Hawtin S., Heng R., Hiestand P., Jahnke W., Koch G., Kroemer M., Möbitz H., Scheufler C., Velcicky J. & Huppertz C. (20101123). In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part I. : Bioorganic & medicinal chemistry letters.

Chicago

Revesz Laszlo, Schlapbach Achim, Aichholz Reiner, Feifel Roland, Hawtin Stuart, Heng Richard, Hiestand Peter, Jahnke Wolfgang, Koch Guido, Kroemer Markus, Möbitz Henrik, Scheufler Clemens, Velcicky Juraj and Huppertz Christine. 20101123. In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part I. : Bioorganic & medicinal chemistry letters.

Harvard

Revesz L., Schlapbach A., Aichholz R., Feifel R., Hawtin S., Heng R., Hiestand P., Jahnke W., Koch G., Kroemer M., Möbitz H., Scheufler C., Velcicky J. and Huppertz C. (20101123). In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part I. : Bioorganic & medicinal chemistry letters.

MLA

Revesz Laszlo, Schlapbach Achim, Aichholz Reiner, Feifel Roland, Hawtin Stuart, Heng Richard, Hiestand Peter, Jahnke Wolfgang, Koch Guido, Kroemer Markus, Möbitz Henrik, Scheufler Clemens, Velcicky Juraj and Huppertz Christine. In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part I. : Bioorganic & medicinal chemistry letters. 20101123.